Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: SPOR Networks in Chronic Disease - LOI

University of British Columbia

$49,530.00

Listening, Learning, Leading: Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD)

EF 2014-15

Résumé
The Can-SOLVE CKD network is a partnership of patients, practitioners, researchers, and policy-makers, which has been assembled to support a unique research program and a pan-Canadian framework to transform the study and care of patients with CKD. We will ensure that the right patient receives the right treatment at the right time. Lead by patient priorities, in collaboration with health policy makers, researchers and clinicians, we will be able(i) to better identify people with CKD across Canada, by moving new methods for diagnosis from the laboratory to clinical care, (ii) to have better access to new and proven therapies for all patients; and (iii) to have a more efficient and effective health system for Canadians by creating, testing and implementing specific models of care, new educational tools, and technology, so that there is excellent communication between providers and patients. Within 5 years, all family members of people with kidney failure, and all Aboriginal Peoples (includes First Nations, Métis and Inuit) will be offered the opportunity to be tested for CKD. We will establish firm targets, based on baseline data, to increase the percentage of patients with diabetes and cardiovascular disease who are evaluated and treated for CKD, double the number of CKD patients involved in clinical trials and observational studies, and ensure that 85% of those with CKD receive the right medications at the right time. These goals will substantially transform the study and care of patients with CKD in Canada
Programme
SPOR Networks in Chronic Disease - LOI
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
323876
Name
Levin Adeera
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
SPOR Networks in Chronic Disease
Projecttitle
Listening, Learning, Leading: Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD)
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$49,530
Cihrequipment2
$0
Programname2
SPOR Networks in Chronic Disease - LOI
Keyworddelim
Biomarker Discovery; Cardiovascular Disease; Chronic Kidney Disease; Clinical Trials; Diabetes; Health Services Research; Novel Diagnostics; Observational Studies; Patient Reported Outcomes; Stem Cells
Abstract
The Can-SOLVE CKD network is a partnership of patients, practitioners, researchers, and policy-makers, which has been assembled to support a unique research program and a pan-Canadian framework to transform the study and care of patients with CKD. We will ensure that the right patient receives the right treatment at the right time. Lead by patient priorities, in collaboration with health policy makers, researchers and clinicians, we will be able(i) to better identify people with CKD across Canada, by moving new methods for diagnosis from the laboratory to clinical care, (ii) to have better access to new and proven therapies for all patients; and (iii) to have a more efficient and effective health system for Canadians by creating, testing and implementing specific models of care, new educational tools, and technology, so that there is excellent communication between providers and patients. Within 5 years, all family members of people with kidney failure, and all Aboriginal Peoples (includes First Nations, Métis and Inuit) will be offered the opportunity to be tested for CKD. We will establish firm targets, based on baseline data, to increase the percentage of patients with diabetes and cardiovascular disease who are evaluated and treated for CKD, double the number of CKD patients involved in clinical trials and observational studies, and ensure that 85% of those with CKD receive the right medications at the right time. These goals will substantially transform the study and care of patients with CKD in Canada
Competitiondate
201501
Approvedterm2
1 yr 0 mth
Pinamesdelim
Levin, Adeera; Harvey, Rebecca; Burns, Kevin D; Laupacis, Andreas; Manns, Braden J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $49,530~ $0~